The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Biomedical Technology

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

High impact information on Biomedical Technology

  • Biochemical markers of bone turnover (urinary deoxypyridinoline cross-links; Quidel Corp., San Diego, CA, USA) and serum osteocalcin (Biomedical Technologies, Stroughton, MA, USA) were obtained at study days 0, 60, 90, and 120 and analyzed by ELISA [1].
  • The use of such decision models enabled the Health Technology Board for Scotland (now a part of NHS Quality Improvement Scotland) to determine that FDG-PET imaging is likely to be cost effective in selected applications and identified long-term patient benefits that it would not be possible to study in a randomised controlled trial [2].
  • METHODS: Results from the previous ad hoc retinal screening service were compared with data from the first year of the new Scottish Diabetes Retinal Screening Programme in Dundee, which was administered according to criteria recommended by the Health Technology Board Scotland [3].
  • New Horizons for the Clinical Specialty of Anti-aging Medicine: The Future with Biomedical Technologies [4].
  • Health technology assessment in clinical biochemistry. Methylmalonic acid: a Danish showcase [5].
 

Associations of Biomedical Technology with chemical compounds

  • The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index) [6].
  • The survey was initiated by the Institute of Biomedical Technology (INBIT) in Patras, Greece, with the active support of national organizations, educational institutions and other parties that share involvement in the overall management of medical devices in Bulgaria [7].
  • The objective of the present study was to evaluate the exposure to formaldehyde in 2 groups each with 18 students in animal health technology from two different training centers (TC) during a 3-hour weekly laboratory session in biology [8].
  • The ongoing adoption of school-based fluoride mouthrinse programs in the U.S. has provided the opportunity to study the issues surrounding the adoption and implementation of a health technology by public schools [9].
  • In the context of the establishment of a Danish Horizon Scanning System (HSS) the views of health care stakeholders and health economists were solicited by means of postal surveys on the need for adaptation of a priority setting instrument for health technology assessment (HTA) [10].
 

Gene context of Biomedical Technology

  • SARS and population health technology [11].
  • In an attempt to evaluate the relevance of CCN3 as a useful tool in modern biomedical technologies, the biological properties of the CCN proteins and the data that established their potential usefulness will briefly be reviewed [12].
  • CLINICAL IMPLICATIONS: Dental practitioners who treat patients who have IDDM need to have a solid foundation in the basic medical sciences and emerging biomedical technology as they each relate to diabetes [13].
  • CONCLUSIONS: Health technology assessment has had very little impact on policy and practice in use of mammography, PSA testing, and ultrasound in pregnancy in Belgium [14].

References

  1. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture. Lane, N.E., Yao, W., Kinney, J.H., Modin, G., Balooch, M., Wronski, T.J. J. Bone Miner. Res. (2003) [Pubmed]
  2. Investing in new technology: the PET experience. Bradbury, I., Facey, K., Laking, G., Sharp, P. Br. J. Cancer (2003) [Pubmed]
  3. Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology. Leese, G.P., Morris, A.D., Swaminathan, K., Petrie, J.R., Sinharay, R., Ellingford, A., Taylor, A., Jung, R.T., Newton, R.W., Ellis, J.D. Diabet. Med. (2005) [Pubmed]
  4. New Horizons for the Clinical Specialty of Anti-aging Medicine: The Future with Biomedical Technologies. Klatz, R. Ann. N. Y. Acad. Sci. (2005) [Pubmed]
  5. Health technology assessment in clinical biochemistry. Methylmalonic acid: a Danish showcase. Hvas, A.M., Ellegaard, J., Lous, J., Nexø, E. Scand. J. Clin. Lab. Invest. (2003) [Pubmed]
  6. The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index). Tanneberger, S., Lelli, G., Martoni, A., Piana, E., Pannuti, F. Journal of chemotherapy (Florence, Italy) (1992) [Pubmed]
  7. A study on the current situation in the biomedical technology and clinical engineering sector in Bulgaria--advances, trends and needs. Panousis, S.G., Malataras, P., Kolitsi, Z., Glouhova, M., Gueorguiev, T., Koleva, K.S., Stavrev, S., Pallikarakis, N. Journal of clinical engineering. (1997) [Pubmed]
  8. Exposure to formaldehyde among animal health students. Dufresne, A., Infante-Rivard, C., Malo, J.L., Gautrin, D. AIHA journal : a journal for the science of occupational and environmental health and safety. (2002) [Pubmed]
  9. A national study of fluoride mouthrinse adoption: implications for school health personnel. Coombs, J.A., Silversin, J.B., Drolette, M.E., Bikofsky, C.G., Ulrich, A.M. The Journal of school health. (1983) [Pubmed]
  10. Priority setting for horizon scanning of new health technologies in Denmark: Views of health care stakeholders and health economists. Douw, K., Vondeling, H., Oortwijn, W. Health policy (Amsterdam, Netherlands) (2006) [Pubmed]
  11. SARS and population health technology. Eysenbach, G. J. Med. Internet Res. (2003) [Pubmed]
  12. The CCN3 (NOV) cell growth regulator: a new tool for molecular medicine. Perbal, B. Expert Rev. Mol. Diagn. (2003) [Pubmed]
  13. Treatment of patients who have type 1 diabetes mellitus: physiological misconceptions and infusion pump therapy. Keene, J.R., Kaltman, S.I., Kaplan, H.M. Journal of the American Dental Association (1939) (2002) [Pubmed]
  14. Impact of health technology assessment on preventive screening in Belgium: case studies of mammography in breast cancer, PSA screening in prostate cancer, and ultrasound in normal pregnancy. Vermeulen, V., Coppens, K., Kesteloot, K. International journal of technology assessment in health care. (2001) [Pubmed]
 
WikiGenes - Universities